4.7 Article

Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Heart failure and COVID-19

Feras Bader et al.

Summary: Heart failure is a common disease state that may occur in COVID-19 patients, presenting unique challenges that require careful understanding of hemodynamics and diagnostics for appropriate triage and management. Abnormal cardiac biomarkers in COVID-19 are influenced by various mechanisms, including viral entry, direct cardiac injury, increased thrombotic activity, and stress cardiomyopathy. Understanding the interaction between heart failure medications, COVID-19 treatments, and managing patients with advanced therapies is crucial for optimal care.

HEART FAILURE REVIEWS (2021)

Article Hematology

Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis

Rushad Patell et al.

Summary: The study found that hospitalized COVID-19 patients who received pharmacologic thromboprophylaxis had lower rates of thrombosis. Patients receiving intermediate-dose thromboprophylaxis or therapeutic anticoagulation had similar rates of thrombosis and bleeding compared to those who received standard-dose pharmacologic thromboprophylaxis.

THROMBOSIS AND HAEMOSTASIS (2021)

Review Medicine, General & Internal

COVID-19 in patients with heart failure: the new and the old epidemic

Nicolo Sisti et al.

Summary: The combination of COVID-19 and cardiovascular diseases can lead to poor prognosis, requiring special care and monitoring for heart failure patients during viral infection.

POSTGRADUATE MEDICAL JOURNAL (2021)

Article Medicine, Research & Experimental

Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study

Garyphallia Poulakou et al.

Summary: This study investigated the efficacy and safety of different anticoagulation dosages in COVID-19 inpatients. The results showed that intermediate or therapeutic dosages significantly reduced the occurrence of adverse events and were associated with decreased levels of certain inflammation biomarkers. A small number of patients experienced minor hemorrhagic complications.

IN VIVO (2021)

Review Emergency Medicine

Cardiovascular complications in COVID-19

Brit Long et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 in the heart and the lungs: could we Notch the inflammatory storm?

Paola Rizzo et al.

BASIC RESEARCH IN CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome

Nicholas S. Hendren et al.

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

The Science Underlying COVID-19 Implications for the Cardiovascular System

Peter P. Liu et al.

CIRCULATION (2020)

Review Cardiac & Cardiovascular Systems

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Bo Li et al.

CLINICAL RESEARCH IN CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

Riccardo M. Inciardi et al.

EUROPEAN HEART JOURNAL (2020)

Review Infectious Diseases

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Jing Yang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

Riccardo M. Inciardi et al.

JAMA CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al.

JAMA CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Epidemiology of heart failure

Amy Groenewegen et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Editorial Material Cardiac & Cardiovascular Systems

End-Stage Heart Failure With COVID-19 Strong Evidence of Myocardial Injury by 2019-nCoV

Nianguo Dong et al.

JACC-HEART FAILURE (2020)

Article Emergency Medicine

SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence

Amanda Baroutjian et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Cardiac Troponin for Assessment of Myocardial Injury in COVID-19 JACC Review Topic of the Week

Yader Sandoval et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Pharmacology & Pharmacy

Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

Fabrizio Cantini et al.

Article Cardiac & Cardiovascular Systems

Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications

Juan R. Rey et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Markers of myocardial injury in the prediction of short-term COVID-19 prognosis

Alicia Calvo-Fernández et al.

Revista española de cardiología (English ed.) (2020)

Article Cardiac & Cardiovascular Systems

Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China

Yudong Peng et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Review Infectious Diseases

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications

Abdullahi Rabiu Abubakar et al.

INFECTION AND DRUG RESISTANCE (2020)

Article Cardiac & Cardiovascular Systems

Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19

Jesus Alvarez-Garcia et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Respiratory System

Prognostic value of NT-proBNP in patients with severe COVID-19

Lei Gao et al.

RESPIRATORY RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

Riccardo M. Inciardi et al.

EUROPEAN HEART JOURNAL (2020)

Article Respiratory System

Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?

Evrim Eylem Akpinar et al.

JORNAL BRASILEIRO DE PNEUMOLOGIA (2019)

Article Cardiac & Cardiovascular Systems

Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

Ovidiu Chioncel et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Review Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2016)

Review Oncology

Cancer treatment and survivorship statistics, 2012

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Review Cardiac & Cardiovascular Systems

Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review

Vijaiganesh Nagarajan et al.